Krebs Biochemicals & Industries (BOM:524518) EV-to-Revenue : 6.61 (As of May. 15, 2024)

Krebs Biochemicals & Industries EV-to-Revenue Chart

Krebs Biochemicals & Industries Annual Data
	Trend	Mar12	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					7.27	9.69	7.77	8.33	6.71

Krebs Biochemicals & Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.99	6.71	2.92	7.20	3.38

Competitive Comparison of Krebs Biochemicals & Industries's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krebs Biochemicals & Industries's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's EV-to-Revenue falls into.

Krebs Biochemicals & Industries EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Krebs Biochemicals & Industries's EV-to-Revenue for today is calculated as:

Krebs Biochemicals & Industries's current Enterprise Value is ₹3,296.6 Mil.
Krebs Biochemicals & Industries's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹499.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries  (BOM:524518) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Krebs Biochemicals & Industries's PS Ratiofor today is calculated as:

Krebs Biochemicals & Industries's share price for today is ₹66.73.
Krebs Biochemicals & Industries's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹23.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description